ascendis transcon
「ascendis transcon」熱門搜尋資訊
![ascendis transcon](https://i0.wp.com/api.multiavatar.com/ascendis+transcon.png?apikey=viVnb6N20jclO8)
「ascendis transcon」文章包含有:「AscendisPharmaOpensCompassionateUseProgramfor...」、「AscendisPharmaPresentsTransCon™PTH...」、「AscendisPharmaProvidesUpdateonRegulatoryReviews...」、「AscendisPharmaReceivesPositiveCHMPOpinionfor...」、「AscendisPresentsTransCon™PTHDataattheAmerican...」、「Oncology」、「One」、「Technology」、「TransConCNP」、「TransConPTH」
查看更多![Ascendis Pharma Opens Compassionate Use Program for ...](https://api.multiavatar.com/Ascendis+Pharma+Opens+Compassionate+Use+Program+for+....png?apikey=viVnb6N20jclO8)
Ascendis Pharma Opens Compassionate Use Program for ...
https://investors.ascendisphar
Ascendis Pharma is applying its innovative TransCon technology platform to build a leading, fully integrated, global biopharma company focused ...
![Ascendis Pharma Presents TransCon™ PTH ...](https://api.multiavatar.com/Ascendis+Pharma+Presents+TransCon%E2%84%A2+PTH+....png?apikey=viVnb6N20jclO8)
Ascendis Pharma Presents TransCon™ PTH ...
https://investors.ascendisphar
TransCon PTH (palopegteriparatide) is an investigational prodrug with sustained release of active parathyroid hormone (PTH [1-34]) administered ...
![Ascendis Pharma Provides Update on Regulatory Reviews ...](https://api.multiavatar.com/Ascendis+Pharma+Provides+Update+on+Regulatory+Reviews+....png?apikey=viVnb6N20jclO8)
Ascendis Pharma Provides Update on Regulatory Reviews ...
https://investors.ascendisphar
Ascendis Pharma Provides Update on Regulatory Reviews of TransCon PTH™ in Hypoparathyroidism · U.S. EAP, which remains open for enrollment for ...
![Ascendis Pharma Receives Positive CHMP Opinion for ...](https://api.multiavatar.com/Ascendis+Pharma+Receives+Positive+CHMP+Opinion+for+....png?apikey=viVnb6N20jclO8)
Ascendis Pharma Receives Positive CHMP Opinion for ...
https://investors.ascendisphar
TransCon PTH is a prodrug of parathyroid hormone (PTH [1-34]) administered once daily. “We are pleased to have received this positive CHMP ...
![Ascendis Presents TransCon™ PTH Data at the American ...](https://api.multiavatar.com/Ascendis+Presents+TransCon%E2%84%A2+PTH+Data+at+the+American+....png?apikey=viVnb6N20jclO8)
Ascendis Presents TransCon™ PTH Data at the American ...
https://investors.ascendisphar
TransCon PTH is an investigational prodrug with sustained release of active parathyroid hormone (PTH [1-34]) administered once daily. TransCon ...
![Oncology](https://api.multiavatar.com/Oncology.png?apikey=viVnb6N20jclO8)
Oncology
https://ascendispharma.com
Our TransCon technologies -- sustained systemic release and localized (intratumoral) release – can be applied to clinically validated targets and pathways from ...
![One](https://api.multiavatar.com/One-Year+Data+from+Phase+3+Trial+of+TransCon%E2%84%A2+PTH+in+....png?apikey=viVnb6N20jclO8)
One
https://investors.ascendisphar
COPENHAGEN, Denmark , June 17, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today reported one-year (Week 52) data from its ...
![Technology](https://api.multiavatar.com/Technology.png?apikey=viVnb6N20jclO8)
Technology
https://ascendispharma.com
TransCon is an innovative technology platform for drug development. It combines known biology with the benefits of prodrug and sustained-release technologies to ...
![TransCon CNP](https://api.multiavatar.com/TransCon+CNP.png?apikey=viVnb6N20jclO8)
TransCon CNP
https://ascendispharma.com
TransCon CNP is an investigational prodrug of CNP in development for the treatment of ACH in children. Designed to provide continuous CNP exposure, the goal of ...
![TransCon PTH](https://api.multiavatar.com/TransCon+PTH.png?apikey=viVnb6N20jclO8)
TransCon PTH
https://ascendispharma.com
TransCon PTH, an investigational long-acting prodrug of parathyroid hormone (PTH) designed to restore physiologic levels of PTH 24 hours a day.